RBC Bioscience

RBC Bioscience Net Change in Cash

The Net Change in Cash of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 14.68 M TWD. In the previous year, Net Change in Cash was -10.75 M TWD — a change of -236.57% (higher).

Net Change in Cash

14.68 MTWD

YoY

-236.57%

Last updated:

Net Change in Cash of RBC Bioscience is 2024 14.68 M TWD. Net Change in Cash of RBC Bioscience was 2023 -10.75 M TWD. It decreases by -236.57% higher compared to the previous year.

The RBC Bioscience Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
-27.74 M TWD
Jan 1, 2019
21.32 M TWD
Jan 1, 2020
80.68 M TWD
Jan 1, 2021
-26.48 M TWD
Jan 1, 2022
-21.54 M TWD
Jan 1, 2023
-10.75 M TWD
Jan 1, 2024
14.68 M TWD
The RBC Bioscience Net Change in Cash history
YEARNet Change in CashYoY
14.68 MTWD-236.57%
-10.75 MTWD-50.08%
-21.54 MTWD-18.66%
-26.48 MTWD-132.82%
80.68 MTWD+278.49%
21.32 MTWD-176.86%
-27.74 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Net Change in Cash of RBC Bioscience is 14.68 M TWD in 2024.

Net Change in Cash of RBC Bioscience changed from -10.75 M TWD to 14.68 M TWD, representing a -236.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — RBC Bioscience

All Key Metrics — RBC Bioscience